We’re increasing our manufacturing capabilities and office space

We’re increasing our manufacturing capabilities and office space
Puretechs new location. We’re increasing our manufacturing capabilities and office space by moving into a new, state-of-the-art manufacturing facility and office space. It spans 40,000 square feet

We’re increasing our manufacturing capabilities and office space

It’s exciting times at Puretech and we’re thrilled to have moved into our new offices and manufacturing facilities.

We are continuing to expand, and to accommodate this, we’re moving into a new, state-of-the-art manufacturing facility and office space. It spans 40,000 square feet and allows us the space to not only increase, but also develop our already impressive capabilities.

Our new facility is very close to our previous facility, still strategically located near Gatwick Airport, providing for superb accessibility for overseas clients and great national transport links for our UK based clients.

You can find our new home at 5 Polar Drive, Salfords, Surrey
RH1 5HW

Proud to be a Platinum sponsor at ISPE 2023

Proud to be a Platinum sponsor at ISPE 2023

Proud to be a Platinum sponsor at ISPE 2023

On 30 November 2023, Puretech will attend ISPE United Kingdom Affiliate Ltd National Conference, hosted at the Coventry Building Society Arena.

This annual conference and exhibition consistently attract a significant audience, making it a key event in the pharmaceutical industry calendar.  Puretech is one of the 45 manufacturers and suppliers participating this year and is also delighted to be a Platinum sponsor for the event, extending its support to the pre-dinner drinks at the prestigious awards ceremony later in the evening.

Our Global Sales Director, James Steptoe is also delivering a talk into how the company played a crucial role in supporting the country’s response during the Covid Pandemic. From contributing to the establishment of critical NHS Nightingale Hospitals to actively participating in the manufacturing process of the Covid vaccine whilst maintaining quality and medical standards throughout.